InflaRx N.V. (IFRX)
NASDAQ: IFRX · Real-Time Price · USD
1.680
-0.040 (-2.33%)
At close: Oct 5, 2026, 4:00 PM EDT
1.690
+0.010 (0.60%)
After-hours: Oct 5, 2026, 4:11 PM EDT
InflaRx Revenue
InflaRx had revenue of -10.10K EUR in the twelve months ending June 30, 2026. In the year 2025, InflaRx had annual revenue of 29.33K, down -82.31%.
Revenue (ttm)
-10.10K EUR
Revenue Growth
-82.31%
P/S Ratio
-21,453.95
Revenue / Employee
-155 EUR
Employees
65
Market Cap
247.58M USD
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 29.33K | -136.46K | -82.31% |
| Dec 31, 2024 | 165.79K | 102.70K | 162.79% |
| Dec 31, 2023 | 63.09K | - | - |
| Dec 31, 2022 | - | - | - |
| Dec 31, 2021 | - | - | - |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| MacroGenics | 175.14M |
| Invivyd | 58.37M |
| Q32 Bio | 53.74M |
| Sutro Biopharma | 45.70M |
| Alector | 13.86M |
| Lineage Cell Therapeutics | 13.08M |
| Evommune | 10.00M |
| Camp4 Therapeutics | 4.22M |
IFRX News
- 3 days ago - InflaRx to Present Late-Breaking Pre-clinical Data on Izicopan at Kidney Week 2026 - GlobeNewsWire
- 4 days ago - InflaRx appoints Alperovich as SVP, Global Head of Clinical Development - TheFly
- 4 days ago - InflaRx Appoints Gabriela Alperovich, MD, PhD, as Senior Vice President & Global Head of Clinical Development - GlobeNewsWire
- 14 days ago - InflaRx to Host Virtual Capital Markets Day - GlobeNewsWire
- 21 days ago - InflaRx Transcript: H.C. Wainwright 28th Annual Global Investment Conference - Transcripts
- 21 days ago - InflaRx initiated with a Buy at Needham - TheFly
- 26 days ago - InflaRx Transcript: 12th Annual Cantor Fitzgerald Global Healthcare Conference - Transcripts
- 6 weeks ago - InflaRx Announces Participation in September Investor Conferences - GlobeNewsWire